share_log

Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk's Drug Still Sees Strong Demand

Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk's Drug Still Sees Strong Demand

儿童肥胖症-美国家长很难获得推荐的治疗,尽管诺和诺德的药物仍然有强烈的需求
Benzinga ·  06/18 12:30

Many U.S. parents seeking help for their child with obesity face challenges accessing the recommended treatment. Leading medical groups advocate for intensive behavioral counseling, requiring 26 hours within a year to teach healthier eating and activity habits.

许多美国父母在寻求帮助孩子减肥方面面临着困难,著名医疗机构主张进行强化行为咨询,每年需提供26个小时的健康饮食和运动方面的培训来帮助孩子建立健康的饮食和运动习惯。

Also Read: Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes.

还阅读:诺和诺德起诉更多美国诊所售假减肥、糖尿病药物semaglutide。

However, as numerous doctors and parents have noted, these programs are often unavailable, have long waitlists, are not covered by insurance, and require significant time commitments.

然而,正如许多医生和父母指出的那样,这些计划通常无法提供,等待名单长,不被保险业覆盖,并需要大量时间。

The U.S. Centers for Disease Control and Prevention (CDC) revealed that fewer than 1% of the nearly 15 million children with obesity receive such structured care, Reuters reported.

消息人士向路透社披露,美国疾病控制和预防中心(CDC)透露,近1500万患有肥胖症的儿童中,不到1%的人接受到这样的结构化保健。

Efforts to expand insurance coverage have stalled. "The coverage for these programs was never good, and we're not seeing any movement toward improvement," said Dr. Joseph Skelton, a professor of pediatrics at Wake Forest University School of Medicine.

扩大保险覆盖范围的努力已经停滞不前。 维克森林大学医学院的儿科教授约瑟夫·斯凯尔顿博士说:“这些计划的保险覆盖从未很好,我们尚未看到任何改善的迹象。”

Obesity rates among U.S. children have climbed from 5% in 1980 to nearly 20% today, the report noted, citing CDC data.

据CDC数据显示,美国儿童的肥胖率从1980年的5%上升到了近20%。

While Novo Nordisk A/S's (NYSE:NVO) Wegovy offers an effective weight-loss solution for adults and adolescents, there is concern about its long-term effects on children's development.

诺和诺德公司(NYSE:NVO)的Wegovy提供了一种有效的减重方案,面向成人和青少年,但有人对它对儿童发育的长期影响表示担忧。

Despite these concerns, demand for Wegovy remains high, with at least 25,000 first-time prescriptions dispensed weekly to adults.

尽管存在这些问题,Wegovy的需求仍然很高,每周至少有25,000份首次处方被发放给成年人。

Changing habits instead of medication is the preferred approach for some families. The report cited Medina's 15-year-old daughter, Jelainie, who enrolled in a healthy weight program at Holyoke Health Center. However, the program has a four-month waitlist, and state Medicaid partially covers participation.

改变饮食习惯而不是药物治疗是一些家庭的首选方法。报告援引Medina的15岁女儿Jelainie的话称,她加入了Holyoke Health Center的健康体重计划。但是,该计划有四个月的等待名单,且州属医疗补助只部分覆盖参加费用。

At Stanford Medicine Children's Health, Dr. Thomas Robinson emphasized that reliance solely on drugs could lead to nutritional deficiencies or eating disorders.

在斯坦福医学儿童健康中心,Thomas Robinson博士强调,仅依赖药物可能会导致营养不良或进食障碍。

The report further noted that Stanford's program teaches families to categorize foods into "red-light" (to be eaten sparingly), "yellow-light," and "green-light" (to be consumed freely) foods, though it costs $3,500 and is not covered by insurance.

报告进一步指出,斯坦福的计划将食物分为“红灯”(应少吃),“黄灯”和“绿灯”(可以自由食用),但该计划需要花费3500美元,且不在保险覆盖范围内。

Efforts to improve insurance coverage for obesity counseling face hurdles. The American Medical Association (AMA) recently rejected a request for a dedicated medical code for the 26-hour counseling program, which would help providers bill for services, per the report.

为肥胖咨询改善保险覆盖范围的努力面临困难。 美国医学协会(AMA)最近拒绝了一项请求,该请求是为26小时辅导计划创建一个专用的医疗代码,以帮助提供者计费,根据报告显示。

The CDC stressed the need for equitable access to both obesity medications and lifestyle treatments to support children's health.

美国疾控中心强调,有必要公平获取肥胖症药物和生活方式治疗,以支持儿童的健康。

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

免责声明本内容部分由人工智能工具生成,并经Benzinga编辑审核和发布。

Photo via Shutterstock

图片来自shutterstock。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发